Mobile app version of munafa.us
Login or Join
 Learn then Earn
stockMarketNEWS

 story : Equillium's stock is up 12% after sharing early data about its investigational lupus treatment #FinanceUSA #StockMarketNEWS Shares of Equillium Inc. gained 12.9% in premarket trading on Tuesday after

@stockMarketNEWS Wed 28 Sep, 2022

Posted in: #FinanceUSA #StockMarketNEWS

Equillium's stock is up 12% after sharing early data about its investigational lupus treatment #FinanceUSA #StockMarketNEWS
Shares of Equillium Inc. gained 12.9% in premarket trading on Tuesday after the company shared a batch of interim data from an early stage trial evaluating its experimental treatment in 13 people with lupus nephritis. Equillium said 83% of the participants enrolled in the study achieved complete or partial response, and about two-thirds had a 80% reduction in urine protein creatinine ratio by week 28. The company expects to share topline data from the Phase 1b open-label proof-of-concept study for itolizumab in mid-2023. Equillium's stock is down 48.8% this year, while the broader S&P 500 has declined 23.3%.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme